Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × OTHER × Fluoxetine × Clear all

Phase

Phase 2 2 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Advanced Cancer 1

Interventions

Exercise 411 Blood Specimen Collection 316 Standard of Care 292 Surveys and Questionnaires 238 Radiosurgery 237 Magnetic Resonance Spectroscopy 232 Educational Status 220 Methods 217 Radiotherapy 216 Early Intervention, Educational 197 Practice Guidelines as Topic 140 Interviews as Topic 134 Biopsy 125 Drug Therapy 118 Acupuncture Therapy 118 Surgical Procedures, Operative 117 Control Groups 115 Therapeutics 99 Palliative Care 94 Resistance Training 92 Counseling 87 Saline Solution 85 Magnetic Resonance Imaging 84 Cyclophosphamide 82 Cisplatin 72 Cognitive Behavioral Therapy 71 Radiofrequency Ablation 70 Radiotherapy, Intensity-Modulated 68 Specimen Handling 67 Colonoscopy 65

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00512291 2011-09-27

Subcutaneous Olanzapine for Hyperactive or Mixed Delirium

M.D. Anderson Cancer Center

Phase NA Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡